The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The TEL / ETV6 gene is located at 12p13 and encodes a member of the ETS family of transcription factors. Translocated ETS leukemia (TEL) is frequently involved in chromosomal translocations in human malignancies, usually resulting in the expression of fusion proteins between the amino-terminal part of TEL and either unrelated transcription factors or protein tyrosine kinases. We have characterized a t(1;12)(q21;p13) translocation in an acute myeloblastic leukemia (AML-M2). At the protein level, the untranslocated TEL copy and, as a result of the t(1;12) translocation, a fusion protein between TEL and essentially all of aryl hydrocarbon receptor nuclear translocator (ARNT) are expressed. The involvement of ARNT in human leukemogenesis has not been previously described. The ARNT protein belongs to a subfamily of the “basic region helix–loop–helix” (bHLH) protein that shares an additional region of similarity called the PAS (Per, ARNT, SIM) domain. ARNT is the central partner of several heterodimeric transcription factors, including those containing the aryl hydrocarbon (dioxin) receptor (AhR) and the hypoxia-inducible factor 1α (HIF1α). Our results show that the TEL-ARNT fusion protein is the crucial product of the translocation and suggest that interference with the activity of AhR or HIF1α can contribute to leukemogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Self-citationHigh frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
Romana, S., Poirel, H., Leconiat, M., Flexor, M., Mauchauffe, M., Jonveaux, P., Macintyre, E., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v86.11.4263.bloodjournal86114263 · Cited by 427
Self-citationThe t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription
Hiebert, S. W., Sun, W., Nathan Davis, J., Golub, T., Shurtleff, S., Buijs, A., Downing, J. R., Grosveld, G., Roussel, M. F., Gary Gilliland, D., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1349 · Cited by 272
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
Self-citationMultilineage embryonic hematopoiesis requires hypoxic ARNT activity
Adelman, D. M., Maltepe, E., & Simon, M. C. (1999) · Genes & Development · doi:10.1101/gad.13.19.2478 · Cited by 185
TEL Is a Sequence-specific Transcriptional Repressor
Lopez, R. G., Carron, C., Oury, C., Gardellin, P., Bernard, O., & Ghysdael, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30132 · Cited by 174
Self-citationBoth TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein
Fenrick, R., Amann, J. M., Lutterbach, B., Wang, L., Westendorf, J. J., Downing, J. R., & Hiebert, S. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6566 · Cited by 162
The TEL gene products: nuclear phosphoproteins with DNA binding properties
Poirel, H., Oury, C., Carron, C., Duprez, E., Laabi, Y., Tsapis, A., Romana, S. P., Mauchauffe, M., Le Coniat, M., Berger, R., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200829 · Cited by 106
Self-citation
Research works printed but not linked: 27
- 10.1038/sj.leu.2401258 · DOI
- 10.1016/0092-8674(94)90322-0 · DOI · Paper page
- 10.1128/MCB.16.8.4107 · DOI · Paper page
- P Papadopoulos, S A Ridge, C A Boucher, C Stocking, L M Wiedemann Cancer Res 55, 34–38 (1995).
- 10.1182/blood.V90.7.2535.2535_2535_2540 · DOI
- 10.1126/science.278.5341.1309 · DOI · Paper page
- 10.1038/ng0298-184 · DOI · Paper page
- 10.1182/blood.V93.4.1355.404k29_1355_1363 · DOI
- 10.1073/pnas.93.25.14845 · DOI · Paper page
- A Buijs, S Sherr, S van Baal, S van Bezouw, D van der Plas, A Geurts van Kessel, P Riegman, R Lekanne Deprez, E Zwarthoff, A Hagemeijer, et al. Oncogene 10, 1511–1519 (1995).
- S A Shurtleff, A Buijs, F G Behm, J E Rubnitz, S C Raimondi, M L Hancock, G C Chan, C H Pui, G Grosveld, J R Downing Leukemia 9, 1985–1989 (1995).
- 10.1182/blood.V88.11.4252.bloodjournal88114252 · DOI
- N A Speck, T Stacy, Q Wang, T North, T L Gu, J Miller, M Binder, M Marin-Padilla Cancer Res 59, 1789s–1793s (1999).
- 10.1182/blood.V87.7.2891.bloodjournal8772891 · DOI · Paper page
- 10.1038/sj.onc.1201817 · DOI
- 10.1038/sj.leu.2400785 · DOI
- O A Bernard, M Mauchauffe, C Mecucci, H Van den Berghe, R Berger Oncogene 9, 1039–1045 (1994).
- 10.1006/geno.1993.1377 · DOI
- 10.1126/science.1852076 · DOI · Paper page
- 10.1101/gad.12.5.607 · DOI · Paper page
- 10.1126/science.278.5340.1068 · DOI · Paper page
- 10.1182/blood.V93.5.1496 · DOI
- D E Bergsagel, O Wong, P L Bergsagel, R Alexanian, K Anderson, R A Kyle, G K Raabe Blood 94, 1174–1182 (1999).
- 10.1016/S0168-9525(98)01558-3 · DOI · Paper page
- 10.1038/20459 · DOI · Paper page
- 10.1073/pnas.95.4.1511 · DOI · Paper page
- S P Romana, M Le Coniat, H Poirel, P Marynen, O Bernard, R Berger Leukemia 10, 167–170 (1996).
Cited by
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703
Hanamura, I., Stewart, J. P., Huang, Y., Zhan, F., Santra, M., Sawyer, J. R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009910 · Cited by 479
ETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
Qiao, F., & Bowie, J. U. (2005) · Science's STKE · doi:10.1126/stke.2862005re7 · Cited by 280
Metadata
- Authors
- Salomon-Nguyen, F., Della-Valle, V., Mauchauffé, M., Busson-Le Coniat, M., Ghysdael, J., Berger, R., & Bernard, O. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-05-30
- Volume
- 97
- Issue
- 12
- Pages
- 6757-6762
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2142574980
- Cited by
- 85
- References
- 14
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.